Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Christopher P Cannon, MD
Harvard Clinical Research Organization and Cardiovascular Division Brigham and Women's Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Site 0020
Huntsville, Alabama, United States
- Site 0005
Mission Viejo, California, United States
- Site 0012
New Haven, Connecticut, United States
- Site 0011
Trumbull, Connecticut, United States
- Site 0016
Pensacola, Florida, United States
- Site 0014
West Des Moines, Iowa, United States
- Site 0018
Bangor, Maine, United States
- Site 0004
Scarborough, Maine, United States
- Site 0008
Boston, Massachusetts, United States
- Site 0001
Burlington, Massachusetts, United States
- Site 0006
Kansas City, Missouri, United States
- Site 0021
Omaha, Nebraska, United States
- Site 0019
Albuquerque, New Mexico, United States
- Site 0002
Toledo, Ohio, United States
- Site 0007
Oklahoma City, Oklahoma, United States
- Site 0009
Philadelphia, Pennsylvania, United States
- Site 0010
Charleston, South Carolina, United States
- Site 0017
Austin, Texas, United States
- Site 0003
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2015
- Primary completion
- 30 Apr 2017
- Completion
- 30 Apr 2017
- Last update posted
- 17 Mar 2020
- Registered enrollment
- 300
- Registry id
- NCT02608099
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.